News InterCure Ltd.

Equities

INCR

IL0011063760

Healthcare Facilities & Services

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 15:24:24 17/07/2025 BST			5-day change	1st Jan Change
510.20 ^ILa	+0.53%		-2.76%	-14.08%

05-01	InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
02-12	Intercure Names Announces Board Changes, Effective February 13, 2025	CI

InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025	05-01	PR
InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	05-01	CI
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak	02-12	PR
Intercure Names Announces Board Changes, Effective February 13, 2025	02-12	CI
InterCure : Immediate Report	02-03	PU
InterCure : A meeting to be held on February 3, 2025-Amendment regarding the private placement	02-02	PU
InterCure : Immediate Report	01-27	PU
InterCure : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JANUARY 27, 2025 Form 6 K	12-20	PU
InterCure : has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility Form 6 K	12-20	PU
InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility	12-20	PR
InterCure Ltd. announced that it has received ILS 35.499998 million in funding	12-18	CI
InterCure : Immediate Report of Meeting	11-25	PU
InterCure : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON DECEMBER 30, 2024 Form 6 K	11-25	PU
InterCure : Immediate Report	11-04	PU
InterCure : Immediate Report	28/10/24	PU
InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million	29/08/24	AQ
InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	29/08/24	CI
InterCure Partners with Cookies to Launch Branded Products in Germany	28/08/24	MT
InterCure Announces Expansion of its Strategic partnership with Cookies to Germany	28/08/24	BU
InterCure Announces Expansion of its Strategic Partnership with Cookies to Germany	28/08/24	CI
InterCure to Participate in Canaccord Genuity’s 8th Annual Global Cannabis Conference	22/05/24	BU
InterCure : Immediate Report	21/05/24	PU
InterCure Announces FY2023 Results: Revenue of NIS 356 million and Adjusted EBITDA of NIS 61 million	01/05/24	BU
InterCure Ltd. Provides Revenue Guidance for the Full Year 2024	01/05/24	CI
InterCure : FORM 20-F For the fiscal year ended December 31, 2023	01/05/24	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News InterCure Ltd.

Equities

INCR

IL0011063760

Healthcare Facilities & Services

Filters